LISABOMGAARSLISA BOMGAARS0.000000000000000.000000000000001961BOMGAARS, LISAProfessorplugins:TwitterTwitterprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 802974Authorship 846963Authorship 889927Authorship 938332Authorship 93671Authorship 940999Authorship 967716Authorship 240525LeukemiaPalliative Care & Rehabilitation MedicineMD AndersonHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessorELIAS JOSEPHJABBOURELIAS JOSEPH JABBOUR9124JABBOUR, ELIAS JOSEPHAssociate ProfessorAuthorship 42951Authorship 458199Authorship 588213Authorship 8105857485107Murray JC, Bomgaars LR, Carcamo B, Mahoney DHAmerican journal of hematologyLymphoid malignancies following Kawasaki disease. Am J Hematol. 1995 Dec; 50(4):299-300.Am J Hematol1995-12-01T00:00:001995Lymphoid malignancies following Kawasaki disease.1102 BATESHouston, 77030TX9332465Bomgaars L, Gunawardena S, Kelley SE, Ramu ACancer chemotherapy and pharmacologyThe inactivation of doxorubicin by long ultraviolet light. Cancer Chemother Pharmacol. 1997; 40(6):506-12.Cancer Chemother Pharmacol1997-01-01T00:00:001997The inactivation of doxorubicin by long ultraviolet light.11304783Evans WE, Hon YY, Bomgaars L, Coutre S, Holdsworth M, Janco R, Kalwinsky D, Keller F, Khatib Z, Margolin J, Murray J, Quinn J, Ravindranath Y, Ritchey K, Roberts W, Rogers ZR, Schiff D, Steuber C, Tucci F, Kornegay N, Krynetski EY, Relling MVJournal of clinical oncology : official journal of the American Society of Clinical OncologyPreponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol. 2001 Apr 15; 19(8):2293-301.J Clin Oncol2001-04-15T00:00:002001Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.11986955Lacayo NJ, Lum BL, Becton DL, Weinstein H, Ravindranath Y, Chang MN, Bomgaars L, Lauer SJ, Sikic BI, Dahl GVLeukemiaPharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. Leukemia. 2002 May; 16(5):920-7.Leukemia2002-05-01T00:00:002002Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia.15459213Bomgaars L, Geyer JR, Franklin J, Dahl G, Park J, Winick NJ, Klenke R, Berg SL, Blaney SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol. 2004 Oct 01; 22(19):3916-21.J Clin Oncol2004-10-01T00:00:002004Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.15514381Chintagumpala M, Blaney SM, Bomgaars LR, Aleksic A, Kuttesch JF, Klenke RA, Berg SLJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer. J Clin Oncol. 2004 Nov 01; 22(21):4394-400.J Clin Oncol2004-11-01T00:00:002004Phase I and pharmacokinetic study of thalidomide with carboplatin in children with cancer.74Professor10Assistant Professor13Associate Dean54Instructor14Associate ProfessorCHSA Pedi-Hospital Medicine11743213Bomgaars L, Berg SL, Blaney SMThe oncologistThe development of camptothecin analogs in childhood cancers. Oncologist. 2001; 6(6):506-16.Oncologist2001-01-01T00:00:002001The development of camptothecin analogs in childhood cancers.16533779Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, Bomgaars L, Blaney SM, Kun LE, Boyett JMClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res. 2006 Mar 01; 12(5):1540-6.Clin Cancer Res2006-03-01T00:00:002006Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).16622268Jeha S, Gaynon PS, Razzouk BI, Franklin J, Kadota R, Shen V, Luchtman-Jones L, Rytting M, Bomgaars LR, Rheingold S, Ritchey K, Albano E, Arceci RJ, Goldman S, Griffin T, Altman A, Gordon B, Steinherz L, Weitman S, Steinherz PJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. J Clin Oncol. 2006 Apr 20; 24(12):1917-23.J Clin Oncol2006-04-20T00:00:002006Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.Authorship 3253389Authorship 325716227400942Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin AM, Grier HE, Weigel B, Blaney SM, Gorlick R, Janeway KAJournal of clinical oncology : official journal of the American Society of Clinical OncologyOutcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward. J Clin Oncol. 2016 09 01; 34(25):3031-8.J Clin Oncol2016-07-11T00:00:002016Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.27052576Manco-Johnson MJ, Bomgaars L, Palascak J, Shapiro A, Geil J, Fritsch S, Pavlova BG, Gelmont DThrombosis and haemostasisEfficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency. Thromb Haemost. 2016 07 04; 116(1):58-68.Thromb Haemost2016-04-07T00:00:002016Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency.17925558Bomgaars LR, Bernstein M, Krailo M, Kadota R, Das S, Chen Z, Adamson PC, Blaney SMJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Oct 10; 25(29):4622-7.J Clin Oncol2007-10-10T00:00:002007Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.19020877Thompson PA, Rosner GL, Matthay KK, Moore TB, Bomgaars LR, Ellis KJ, Renbarger J, Berg SLCancer chemotherapy and pharmacologyImpact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study. Cancer Chemother Pharmacol. 2009 Jul; 64(2):243-51.Cancer Chemother Pharmacol2008-11-20T00:00:002008Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.16197721Bomgaars L, McLeod HLCancer journal (Sudbury, Mass.)Pharmacogenetics and pediatric cancer. Cancer J. 2005 Jul-Aug; 11(4):314-23.Cancer J2005-07-01T00:00:002005Pharmacogenetics and pediatric cancer.16317728Bomgaars LR, Megason GC, Pullen J, Langevin AM, Dale Weitman S, Hershon L, Kuhn JG, Bernstein M, Blaney SMPediatric blood & cancerPhase I trial of irofulven (MGI 114) in pediatric patients with solid tumors. Pediatr Blood Cancer. 2006 Aug; 47(2):163-8.Pediatr Blood Cancer2006-08-01T00:00:002006Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors.15793249Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MWDiabetesThe role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes. 2005 Apr; 54(4):1100-7.Diabetes2005-04-01T00:00:002005The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes.22959138Richard AA, Kim S, Moffett BS, Bomgaars L, Mahoney D, Yee DLThe Journal of pediatricsComparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin. J Pediatr. 2013 Feb; 162(2):293-6.J Pediatr2012-09-05T00:00:002012Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin.17301735Blake MJ, Gaedigk A, Pearce RE, Bomgaars LR, Christensen ML, Stowe C, James LP, Wilson JT, Kearns GL, Leeder JSClinical pharmacology and therapeuticsOntogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin Pharmacol Ther. 2007 Apr; 81(4):510-6.Clin Pharmacol Ther2007-02-14T00:00:002007Ontogeny of dextromethorphan O- and N-demethylation in the first year of life.18154909Krull KR, Brouwers P, Jain N, Zhang L, Bomgaars L, Dreyer Z, Mahoney D, Bottomley S, Okcu MFThe Journal of pediatricsFolate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr. 2008 Jan; 152(1):101-5.J Pediatr2007-10-24T00:00:002007Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors.18253960Yee DL, Dinu BR, Sun CW, Edwards RM, Justino H, Teruya J, Bray PF, Bomgaars LPediatric blood & cancerLow prevalence and assay discordance of "aspirin resistance" in children. Pediatr Blood Cancer. 2008 Jul; 51(1):86-92.Pediatr Blood Cancer2008-07-01T00:00:002008Low prevalence and assay discordance of "aspirin resistance" in children.18278496Thompson PA, Gupta M, Rosner GL, Yu A, Barrett J, Bomgaars L, Bernstein ML, Blaney SM, Mondick JCancer chemotherapy and pharmacologyPharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group. Cancer Chemother Pharmacol. 2008 Nov; 62(6):1027-37.Cancer Chemother Pharmacol2008-02-16T00:00:002008Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group.19273678S?ez-Llorens X, Yogev R, Arguedas A, Rodriguez A, Spigarelli MG, De Le?n Castrej?n T, Bomgaars L, Roberts M, Abrams B, Zhou W, Looby M, Kaiser G, Hamed KAntimicrobial agents and chemotherapyPharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection. Antimicrob Agents Chemother. 2009 May; 53(5):1912-20.Antimicrob Agents Chemother2009-03-09T00:00:002009Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.Authorship 652273127556152Steiner ME, Bomgaars LR, Massicotte MP, Berlin Heart EXCOR Pediatric VAD IDE study investigatorsASAIO journal (American Society for Artificial Internal Organs : 1992)Antithrombotic Therapy in a Prospective Trial of a Pediatric Ventricular Assist Device. ASAIO J. 2016 Nov/Dec; 62(6):719-727.ASAIO J2016-11-01T00:00:002016Antithrombotic Therapy in a Prospective Trial of a Pediatric Ventricular Assist Device.20097410Thornburg CD, Jones E, Bomgaars L, Gage BFThrombosis researchPediatric warfarin practice and pharmacogenetic testing. Thromb Res. 2010 Aug; 126(2):e144-6.Thromb Res2010-01-25T00:00:002010Pediatric warfarin practice and pharmacogenetic testing.20332358Raman VS, Mason KJ, Rodriguez LM, Hassan K, Yu X, Bomgaars L, Heptulla RADiabetes careThe role of adjunctive exenatide therapy in pediatric type 1 diabetes. Diabetes Care. 2010 Jun; 33(6):1294-6.Diabetes Care2010-03-23T00:00:002010The role of adjunctive exenatide therapy in pediatric type 1 diabetes.22069087Moffett BS, Ung M, Bomgaars LPediatric blood & cancerRisk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients. Pediatr Blood Cancer. 2012 Jun; 58(6):941-4.Pediatr Blood Cancer2011-11-08T00:00:002011Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients.21910213Klaassen RJ, Mathias SD, Buchanan G, Bussel J, Deuson R, Young NL, Collier A, Bomgaars L, Blanchette VPediatric blood & cancerPilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP). Pediatr Blood Cancer. 2012 Mar; 58(3):395-8.Pediatr Blood Cancer2011-09-09T00:00:002011Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).15768380Bomgaars L, Kerr J, Berg S, Kuttesch J, Klenke R, Blaney SMPediatric blood & cancerA phase I study of irinotecan administered on a weekly schedule in pediatric patients. Pediatr Blood Cancer. 2006 Jan; 46(1):50-5.Pediatr Blood Cancer2006-01-01T00:00:002006A phase I study of irinotecan administered on a weekly schedule in pediatric patients.17136402Thompson PA, Murry DJ, Rosner GL, Lunagomez S, Blaney SM, Berg SL, Camitta BM, Dreyer ZE, Bomgaars LRCancer chemotherapy and pharmacologyMethotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2007 May; 59(6):847-53.Cancer Chemother Pharmacol2006-11-29T00:00:002006Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.17332297Horton TM, Pati D, Plon SE, Thompson PA, Bomgaars LR, Adamson PC, Ingle AM, Wright J, Brockman AH, Paton M, Blaney SMClinical cancer research : an official journal of the American Association for Cancer ResearchA phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study. Clin Cancer Res. 2007 Mar 01; 13(5):1516-22.Clin Cancer Res2007-03-01T00:00:002007A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.17909804Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF, Aikin A, Whitcomb P, Renbarger J, Lieberman FS, Berg SL, Blaney SMCancer chemotherapy and pharmacologyPhase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemother Pharmacol. 2008 Jul; 62(2):355-61.Cancer Chemother Pharmacol2007-10-02T00:00:002007Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.18561175Bomgaars L, Thompson P, Berg S, Serabe B, Aleksic A, Blaney SPediatric blood & cancerValacyclovir and acyclovir pharmacokinetics in immunocompromised children. Pediatr Blood Cancer. 2008 Oct; 51(4):504-8.Pediatr Blood Cancer2008-10-01T00:00:002008Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.19652076Jeha S, Razzouk B, Rytting M, Rheingold S, Albano E, Kadota R, Luchtman-Jones L, Bomgaars L, Gaynon P, Goldman S, Ritchey K, Arceci R, Altman A, Stine K, Steinherz L, Steinherz PJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia. J Clin Oncol. 2009 Sep 10; 27(26):4392-7.J Clin Oncol2009-08-03T00:00:002009Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.20576051Bomgaars L, Carberry K, Fraser C, West A, Teruya JCongenital heart diseaseDevelopment of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases. Congenit Heart Dis. 2010 May-Jun; 5(3):303-8.Congenit Heart Dis2010-05-01T00:00:002010Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.21502541Bussel JB, Buchanan GR, Nugent DJ, Gnarra DJ, Bomgaars LR, Blanchette VS, Wang YM, Nie K, Jun SBloodA randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood. 2011 Jul 07; 118(1):28-36.Blood2011-04-18T00:00:002011A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia.22873533Fraser CD, Jaquiss RD, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, Naftel DC, Ichord RN, Bomgaars L, Tweddell JS, Massicotte MP, Turrentine MW, Cohen GA, Devaney EJ, Pearce FB, Carberry KE, Kroslowitz R, Almond CS, Berlin Heart Study InvestigatorsThe New England journal of medicineProspective trial of a pediatric ventricular assist device. N Engl J Med. 2012 Aug 09; 367(6):532-41.N Engl J Med2012-08-09T00:00:002012Prospective trial of a pediatric ventricular assist device.Authorship 879395328921890Halton JML, Albisetti M, Biss B, Bomgaars L, Brueckmann M, Gropper S, Harper R, Huang F, Luciani M, Maas H, Tartakovsky I, Mitchell LGJournal of thrombosis and haemostasis : JTHPhase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability. J Thromb Haemost. 2017 11; 15(11):2147-2157.J Thromb Haemost2017-10-26T00:00:002017Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.true1ProfessorProfessortrue1ProfessorProfessortrue1InstructorInstructortrue1ProfessorProfessortrue1InstructorInstructortrue1ProfessorProfessorAuthorship 1074941Authorship 8909932Authorship 890994230046763Luciani M, Albisetti M, Biss B, Bomgaars L, Brueckmann M, Chalmers E, Gropper S, Halton JML, Harper R, Huang F, Manastirski I, Mitchell LG, Tartakovsky I, Wang B, Brand?o LRResearch and practice in thrombosis and haemostasisPhase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design. Res Pract Thromb Haemost. 2018 Jul; 2(3):580-590.Res Pract Thromb Haemost2018-04-24T00:00:002018Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design.30046738Albisetti M, Biss B, Bomgaars L, Brand?o LR, Brueckmann M, Chalmers E, Gropper S, Harper R, Huang F, Luciani M, Manastirski I, Mitchell LG, Tartakovsky I, Wang B, Halton JMLResearch and practice in thrombosis and haemostasisDesign and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolism. Res Pract Thromb Haemost. 2018 Apr; 2(2):347-356.Res Pract Thromb Haemost2018-03-25T00:00:002018Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolism.true1InstructorInstructorD002166Chemicals & Drugs2065150.798588CamptothecinAuthorship 1084438D014859Chemicals & Drugs1021510.879338WarfarinD054556Disorders1813350.690441Venous ThromboembolismD000925Chemicals & Drugs3657840.641324AnticoagulantsAuthorship 934285630091945Hawkins DS, Chi YY, Anderson JR, Tian J, Arndt CAS, Bomgaars L, Donaldson SS, Hayes-Jordan A, Mascarenhas L, McCarville MB, McCune JS, McCowage G, Million L, Morris CD, Parham DM, Rodeberg DA, Rudzinski ER, Shnorhavorian M, Spunt SL, Skapek SX, Teot LA, Wolden S, Yock TI, Meyer WHJournal of clinical oncology : official journal of the American Society of Clinical OncologyAddition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2018 09 20; 36(27):2770-2777.J Clin Oncol2018-08-09T00:00:002018Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.Authorship 1088071Department of AnesthesiologyDepartment of MedicineDepartment of PediatricsDepartment of Pathology & ImmunologyPediatrics-Hem/Onc Clin ResearchAnesthesiologyMedicine-NephrologyPathologyPediatrics-Hematology & OncologyPediatrics-OncologyBaylor College of Medicine1.449140.00293713264research areas2.020060.019142917coauthor of43.0715.9415360similar to1152selected publicationsBRANDEGILLBRANDE GILL0.000000000000000.000000000000001860GILL, BRANDEInstructorSTACEYBERGSTACEY BERG0.000000000000000.000000000000003449BERG, STACEYProfessorJUNTERUYAJUN TERUYA29.70508570000000-95.40180870000000410TERUYA, JUNProfessorSUSANBLANEYSUSAN BLANEY0.000000000000000.000000000000003463BLANEY, SUSANProfessorSHILEYAGUILARSHILEY AGUILAR0.000000000000000.000000000000004289AGUILAR, SHILEYInstructorSTEPHANIEGRUNERSTEPHANIE GRUNER0.000000000000000.000000000000001859GRUNER, STEPHANIEInstructorAuthorship 940898530810947Beechinor RJ, Thompson PA, Hwang MF, Vargo RC, Bomgaars LR, Gerhart JG, Dreyer ZE, Gonzalez DClinical pharmacokineticsThe Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group. Clin Pharmacokinet. 2019 07; 58(7):899-910.Clin Pharmacokinet2019-07-01T00:00:002019The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group.ZOANNDREYERZOANN DREYER0.000000000000000.000000000000002981DREYER, ZOANNProfessorBRADYMOFFETTBRADY MOFFETT0.000000000000000.000000000000004738MOFFETT, BRADYAssistant ProfessorMARIKAHIGHBERGERMARIKA HIGHBERGER0.000000000000000.00000000000000959HIGHBERGER, MARIKAAssistant ProfessorAuthorship 1262033D00006960414260.97984Dabigatran23606286Moffett BS, Kim S, Bomgaars LRPediatric blood & cancerReadmissions for warfarin-related bleeding in pediatric patients after hospital discharge. Pediatr Blood Cancer. 2013 Sep; 60(9):1503-6.Pediatr Blood Cancer2013-04-20T00:00:002013Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge.2025-02-28NIHHAWKINS, DOUGLAS S2014-04-11COG NCTN Network Group Operations CenterU10CA180886Authorship 1109213Authorship 1115915Authorship 962179231805182Brand?o LR, Albisetti M, Halton J, Bomgaars L, Chalmers E, Mitchell LG, Nurmeev I, Svirin P, Kuhn T, Zapletal O, Tartakovsky I, Simetzberger M, Huang F, Sun Z, Kreuzer J, Gropper S, Brueckmann M, Luciani M, DIVERSITY Study InvestigatorsBloodSafety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. Blood. 2020 02 13; 135(7):491-504.Blood2020-02-13T00:00:002020Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.true1ProfessorProfessor2025-06-30NIHALLEN, CARL E;JOLOBA, MOSES LUTAAKOME;SCHEURER, MICHAEL E2020-07-25Pediatric HIV/AIDS & Infection-Related Malignancies Research Consortium for sub-Saharan Africa (PARCA)U54CA254569Authorship 1006582233290737Halton J, Brand?o LR, Luciani M, Bomgaars L, Chalmers E, Mitchell LG, Nurmeev I, Sharathkumar A, Svirin P, Gorbatikov K, Tartakovsky I, Simetzberger M, Huang F, Sun Z, Kreuzer J, Gropper S, Reilly P, Brueckmann M, Albisetti M, DIVERSITY Trial InvestigatorsThe Lancet. HaematologyDabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial. Lancet Haematol. 2021 Jan; 8(1):e22-e33.Lancet Haematol2020-12-05T00:00:002020Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.Authorship 1012384233636042R?shammar D, Huang F, Albisetti M, Bomgaars L, Chalmers E, Luciani M, Halton J, Mitchell LG, Bergstrand M, Ibrahim MMA, Joseph D, Tartakovsky I, Gropper S, Brueckmann M, Brand?o LRJournal of thrombosis and haemostasis : JTHPharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism. J Thromb Haemost. 2021 05; 19(5):1259-1270.J Thromb Haemost2021-03-26T00:00:002021Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism.DAVIDFARAONIDAVID FARAONI16881FARAONI, DAVIDProfessorAuthorship 1029295734496122Collier AB, Krailo MD, Dang HM, DuBois SG, Hawkins DS, Bernstein ML, Bomgaars LR, Reed DR, Gorlick RG, Janeway KAPediatric blood & cancerOutcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2021 12; 68(12):e29333.Pediatr Blood Cancer2021-09-08T00:00:002021Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group.true1ProfessorProfessortrue1ProfessorProfessorCo-InvestigatorSubaward PISubaward PI2025-07-31NIHPOLLOCK, BRAD H2014-08-01Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grantUG1CA189955Twitter Tweets Harvard TweetsAuthorship 10527353Authorship 1052736335909257Mitchell LG, R?shammar D, Huang F, Albisetti M, Brand?o LR, Bomgaars L, Chalmers E, Halton J, Luciani M, Joseph D, Tartakovsky I, Gropper S, Brueckmann MThrombosis and haemostasisAnticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials. Thromb Haemost. 2022 Sep; 122(9):1573-1583.Thromb Haemost2022-07-31T00:00:002022Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials.36150047Brand?o LR, Tartakovsky I, Albisetti M, Halton J, Bomgaars L, Chalmers E, Luciani M, Saracco P, Felgenhauer J, Lvova O, Simetzberger M, Sun Z, Mitchell LGBlood advancesDabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia. Blood Adv. 2022 11 22; 6(22):5908-5923.Blood Adv2022-11-22T00:00:002022Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.Authorship 1199401true1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant ProfessorAuthorship 222929Authorship 1089034438348778Albisetti M, Tartakovsky I, Halton J, Bomgaars L, Chalmers E, Mitchell LG, Luciani M, Nurmeev I, Gorbatikov K, Miede C, Brueckmann M, Brand?o LR, Study InvestigatorsJournal of the American Heart AssociationDabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e028957.J Am Heart Assoc2024-02-13T00:00:002024Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease.true1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorAuthorship 238851WOLFGANGWINKELMAYERWOLFGANG WINKELMAYER7258WINKELMAYER, WOLFGANGProfessorAuthorship 141409324399058Moffett BS, Cabrera AG, Teruya J, Bomgaars LASAIO journal (American Society for Artificial Internal Organs : 1992)Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study. ASAIO J. 2014 Mar-Apr; 60(2):211-5.ASAIO J2014-03-01T00:00:002014Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study.Authorship 467248Authorship 345111Authorship 356962Authorship 422766Authorship 145971524614609Hundalani SG, Nguyen KT, Soundar E, Kostousov V, Bomgaars L, Moise A, Hui SK, Teruya JPediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care SocietiesAge-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014 Jun; 15(5):e198-205.Pediatr Crit Care Med2014-06-01T00:00:002014Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.Authorship 441991Authorship 471634Authorship 51525Authorship 598428Authorship 620605Authorship 63063Authorship 152825124458250Moffett BS, Bomgaars LRJournal of pediatric hematology/oncologyResponse to warfarin therapy in obese pediatric patients dosed according to institutional guidelines. J Pediatr Hematol Oncol. 2014 Nov; 36(8):e487-9.J Pediatr Hematol Oncol2014-11-01T00:00:002014Response to warfarin therapy in obese pediatric patients dosed according to institutional guidelines.Authorship 656693Authorship 678911Authorship 723277